Biomedical research lives on the cutting edge of knowledge, but biomedical researchers live in the here-and-now. Like everyone, they must play by the rules.
That means understanding the rules … which are pretty complicated.
Take Guidelines Appendix M, extensively revised a year ago. Appendix M-I-A requires registration of protocols with the Office of Science Policy, and Appendix M-I-C requires scheduled and incidental progress and safety. Principal Investigators are responsible for making sure reporting requirements are fulfilled but may delegate some reporting.
Got that? Well then …
Mark your calendar for Tuesday, June 5, when WCG/CenterWatch and FDAnews present a FREE sponsored webinar with a leading biomedical researcher. Daniel Kavanagh Ph.D. is Senior Director-Biosafety and Gene Therapy at WCG Biosafety, a division of the WIRB-Copernicus Group, with dozens of publications and honors to his record.
Over the course of an intense hour, Dr. Kavanagh will walk you through:
The NIH is the go-to agency for biomedical research. Understanding its processes means speedier grants, fewer project delays and, ultimately, getting to market first. Sharpen your competitive edge. Sign up now for this FREE webinar.
Who Will Benefit
Sign Up for FREE Below
Senior Director-Biosafety and Gene Therapy
WCG Biosafety, a division of the WIRB-Copernicus Group
Daniel Kavanagh Ph.D. is Senior Director-Biosafety and Gene Therapy at WCG Biosafety, a division of the WIRB-Copernicus Group. Prior to joining WCG he was Assistant Professor of Medicine at Harvard Medical School, Assistant Immunologist at the Massachusetts General Hospital, and a Principal Investigator studying infectious diseases at the Ragon Institute of MGH, MIT, and Harvard. Research interests focus on factors that modulate the T cell response to infectious diseases and tumors, including antigen processing, TCR signaling, costimulation, and checkpoint signaling integration. He has coauthored 37 peer-reviewed publications, with primary authorship in high-impact journals such as Nature Immunology, Blood, The Journal of Experimental Medicine, and the Journal of Immunology.